2019 Annual Meeting | C195 - Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease

Date Wednesday 05/08/19

Time 03:30 PM - 05:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Madhu Soni, MD, F�鶹��ýӳ��

Topic(s) Neuro Trauma, Critical Care, and Sports Neurology, Neuromuscular and Clinical Neurophysiology (EMG), General Neurology: Overview

Learning Objectives Participants should be able to discuss current treatments and evidence-based guidelines for common neurocritical care conditions, myasthenia gravis, and autoimmune necrotizing myopathy.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM EDT	Introduction	Introduction Madhu Soni, MD, F�鶹��ýӳ��
03:35 PM - 04:20 PM EDT	Speaker	Update on Therapy in Neurocritical Care Thomas P. Bleck, MD, F�鶹��ýӳ��
04:20 PM - 04:30 PM EDT	Q&A	Questions and Answers Thomas P. Bleck, MD, F�鶹��ýӳ��
04:30 PM - 04:55 PM EDT	Speaker	Myasthenia Gravis Kerry H. Levin, MD, F�鶹��ýӳ��
04:55 PM - 05:20 PM EDT	Speaker	Autoimmune Necrotizing Myopathy Madhu Soni, MD, F�鶹��ýӳ��
05:20 PM - 05:30 PM EDT	Q&A	Questions and Answers Madhu Soni, MD, F�鶹��ýӳ��, Kerry H. Levin, MD, F�鶹��ýӳ��

Faculty Disclosures
Madhu Soni, MD, F�鶹��ýӳ��	Dr. Soni has received personal compensation in the range of $500-$4,999 for serving as a Physician Lead (Honorarium) in Women Leading in Neurology Program with �鶹��ýӳ��.
Thomas P. Bleck, MD, F�鶹��ýӳ��	Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH.
Kerry H. Levin, MD, F�鶹��ýӳ��	Dr. Levin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levin has received publishing royalties from a publication relating to health care. Dr. Levin has received publishing royalties from a publication relating to health care.